Correction: Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation

A Correction on
Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation

by Al Atya, A. K., Belguesmia, Y., Chataigne, G., Ravallec, R., Vachée, A., Szunerits, S., Boukherroub, R., and Drider, D. (2016). Front. Microbiol. 7:817. doi: 10.3389/fmicb.2016.00817

There was a mistake in Figure 4 as published. A wrong figure appeared.

The corrected Figure 4 and it's caption appear below.

Figure 4

Figure 4. Biofilms formation by MRSA-S1 on AISI 304L stainless steel slides conditioned with antimicrobial agents for 2 h and then washed and inoculated with 2 ml of 10⁷ CFU/ml MRSA-S1 culture before removing, washing and adding TSB-YE medium for 0, 3, 6, and 24 h of incubation at 37°C. Concentrations of antimicrobial agents used were 8 mg/L for erythromycin, 0.03 mg/L for rifampin, 200 mg/L for enterocin DD28, 50 mg/L + 1 mg/L for enterocin DD28 + erythromycin, respectively. Biofilms were stained with the BacLight Live/Dead Viability Kit and imaged by epifluorescence microscopy after staining pattern for live cells (green) and dead cells (red). The experiments were performed at least twice and representative images are shown.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.